All Updates

All Updates

icon
Filter
Funding
Adcytherix raises EUR 30 million in seed funding to develop next-generation antibody drug conjugates
Precision Medicine
Jun 11, 2024
This week:
Partnerships
Sheeva.AI and P97 Networks partner for in-car payment solutions at fuel stations
Auto Tech
Today
Product updates
Food Cycle Science launches 'Food Cycler Eco 3,' a household food waste processing bin
Food Waste
Yesterday
Partnerships
Von Holzhausen and Herman Miller partner to launch plant-based leather Eames Chair
Bio-based Materials
Yesterday
Partnerships
Volvo Cars partners with Beijing Shougang and Zhejiang Yiyun for automotive steel recycling
Waste Recovery & Management Tech
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Carbon Capture, Utilization & Storage (CCUS)
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Alternative Energy
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
Pet Care Tech
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
InsurTech: Personal Lines
Yesterday
M&A
Applied Systems acquires Planck for undisclosed sum to expand AI capabilities
InsurTech: Infrastructure
Yesterday
Product updates
Monzo launches pension consolidation product
Neobanks
Yesterday
Precision Medicine

Precision Medicine

Jun 11, 2024

Adcytherix raises EUR 30 million in seed funding to develop next-generation antibody drug conjugates

Funding

  • Adcytherix has raised EUR 30 million (USD 32.2 million) in a seed funding round led by Pontifax and supported by Pureos Bioventures, RA Capital Management, Dawn Biopharma, and company management.

  • The funds raised are intended to be channeled towards R&D efforts to develop new antibody-drug conjugates (ADCs) for treating diseases with a high unmet need, such as cancer.

  • Based in France, Adcytherix is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) to treat diseases with a high unmet need.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.